Supreme Court: Compassionate Appointees Cannot Later Claim Entitlement to a Higher Post  ||  NCLAT New Delhi: Insolvency Pleas Cannot Be Admitted When Information Utility Records Show a Dispute  ||  NCLAT: Issuing Cheques For Another Entity’s Liabilities Does not Constitute Operational Debt  ||  NCLAT: SEBI Penalties Imposed After Liquidation Begins are Not Admissible as Claims  ||  NCLT Reiterates That an Auction Purchaser is Not Liable For a Corporate Debtor’s Electricity Dues  ||  Delhi HC Upholds Interim Injunction Against 'Power Flex' in Bata’s Trademark Infringement Case  ||  Calcutta High Court: Mere Presence of Alcohol in Post-Mortem Cannot Bar Compensation to Heirs  ||  Kerala High Court: Review Petition Cannot Be Entertained Against an Order Refusing Arbitration  ||  J&K High Court: Umadevi Judgment Does not Justify Perpetual Temporary Employment  ||  SC: Public Premises Act Prevails over State Rent Laws For Evicting Unauthorised Occupants    

Delhi HC Seeks Centre's Response on How It Intends to Obtain Supply of Tocilizumab Drug - (17 May 2021)

CIVIL

Delhi High Court has sought Centre's response on the demand of Tocilizumab drug and how does the Centre intend to obtain the supplies of the said drug through Roche India and other global manufacturers, observing that no assurance was given by Roche India, which enjoys the license of manufacturing Tocilizumab 400 mg, if any further stock can be supplied to India.

Tags : DELHI HIGH COURT   SUPPLY OF TOCILIZUMAB DRUG  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved